
-
2007
Company Description
Minerva Neurosciences is a clinical-stage biopharmaceutical company
Minerva Neurosciences is a clinical-stage biopharmaceutical company focused on the development and commercialization of a portfolio of product candidates to treat central nervous system (CNS) diseases. Our goal is to transform the lives of patients with improved therapeutic options and a patient-centric focus. Leveraging extensive domain expertise, we have identified and acquired or in-licensed a portfolio of development-stage proprietary compounds with innovative mechanisms of action.
-
Manufacturer:
Science and Engineering -
Formed:
2007 -
Company Website:
-
Company E-mail:
-
Company Address:
245 First Street, Suite 1800Cambridge, MAUnited States -
CEO:
- Remy Luthringer
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits